BARTLETT & CO. WEALTH MANAGEMENT LLC
Position in CADL — Candel Therapeutics, Inc.
CIK 2010186
CINCINNATI, OH
Position in CADL
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$36,256
+$19,008 QoQ
Shares Held
3,520
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#108
of 138 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARTLETT & CO. WEALTH MANAGEMENT LLC holds $1,629,105 across 20 Biotechnology names. CADL ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
11,100 | $605,394 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
4,144 | $324,350 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
575 | $285,619 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
363 | $226,345 | |
| 5 | INCY |
Incyte Corp
|
363 | $41,149 | |
| 6 | DNLI |
Denali Therapeutics Inc.
|
1,500 | $38,580 | |
| 7 | CADL |
Candel Therapeutics, Inc.
This page
|
3,520 | $36,256 | |
| 8 | GUTS |
Fractyl Health, Inc.
|
25,000 | $19,850 |
All Filings in CADL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,256 | 3,520 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $17,248 | 3,520 | Shares | Sole | 2026-05-06 | |
| No filing history on record for this holder in this stock. | ||||||